The University of Cincinnati started a clinical trial for investigational treatments targeting prosthetic joint infections (PJI), with initial patient enrollments reported. The study is led by Dr. T. Toan Le of the university’s Department of Orthopaedic Surgery, aiming to address a complication that remains difficult to treat clinically due to persistent infection risk around implanted hardware. For orthopedics and infectious disease stakeholders, the trial signals continued investment in targeted approaches rather than relying only on broad-spectrum regimens and device-management strategies. The first enrollments also set expectations for near-term recruitment updates and early safety signals as the trial progresses.